BioSpace News Archive

With a goal of patient empowerment, the American College of Lifestyle Medicine has announced a Type 2 Diabetes Bill of Rights to raise consumer awareness regarding patient rights to evidence-based Lifestyle Medicine therapeutic approaches as a first-line treatment option. ACLM believes that offering this treatment option is vital at

TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient, CRO-independent product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the U.S., today announced financial results for the third quarter ended September 30, 2020. The Company will host a confer

Quidel Corporation, a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced that it will present at the following upcoming conferences

Liminal BioSciences Inc. (Nasdaq: LMNL) (“Liminal BioSciences” or the “Company”), a clinical-stage biopharmaceutical company, today announced that it will now report its financial results for the third quarter ended September 30 th 2020 on Thursday November 12, 2020 after market close.

Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune and other major diseases, announces that the results of the Phase 1a study (NCT03763149) of C

Phagenesis Ltd, a leading innovator in the treatment of dysphagia, is pleased to announce the publication of the largest and most complex study on Pharyngeal Electrical Stimulation in the journal EClinicalMedicine-The Lancet.

Stryker (NYSE: SYK) announced today that it intends to complete the acquisition of Wright Medical Group N.V. (NASDAQ: WMGI) by effectuating the mergers described in the tender offer statement on Schedule TO filed by Stryker B.V., an indirect, wholly owned subsidiary of Stryker, with the U.S. Securities and Exchange Commission on December 13, 2019, as amended.

Strategic hires to its senior leadership team include former AWS executives to oversee product and engineering strategy

Bioventus to Provide CVS Caremark ® with its Portfolio of Preferred Options for Knee Osteoarthritis Patients Seeking Pain Relief

In the past three years, new research has found that peanuts and peanut butter can be a powerful tool to help diabetics live a healthier life and prevent the onset of type 2 diabetes in others, according to The Peanut Institute.